Orphazyme
DenmarkWho owns Orphazyme?
Orphazyme is a Danish Biotech company, currently owned by Eurazeo since 2017. It changed hands in 2017, when Sunstone Life Science Ventures sold.
Hand-verified · updated 2026-09-30
Open JSON · CC-BY
Key facts
Ownership history
2 ownership periods
Sunstone Life Science Ventures took Orphazyme public via IPO in 2017 after 6 years.
More from Kurma Biofund III
Other portfolio companies in the same fund.
France
Netherlands
More PE-backed in Biotech
Comparable biotech deals from other GPs.
USQuestions
Who owns Orphazyme?
Orphazyme is currently owned by Eurazeo, through Kurma Biofund III, since 2017.
When did Eurazeo acquire Orphazyme?
Eurazeo acquired Orphazyme in 2017.
Who did Orphazyme sell to?
Sunstone Life Science Ventures sold Orphazyme to Eurazeo in 2017 (IPO).
Who has owned Orphazyme over time?
Orphazyme has been through 2 private-equity ownership periods: Sunstone Life Science Ventures · via Sunstone Life Science Ventures III · 2011–2017 · sold to Eurazeo · (IPO); Eurazeo · via Kurma Biofund III · since 2017.